March 5, 1999 Douglas S. Krupp The Berkshire Group One Beacon Street, Suite 1550 Boston, MA 02108 Dear Douglas: Reference is made to the letter dated February 22, 1999 among the three of us (the "Term Sheet Letter"). This is to confirm our agreement...Term Sheet Amendment • March 8th, 1999 • Berkshire Companies Limited Partnership • Real estate investment trusts
AMENDMENT NO.1 TO TERM SHEETTerm Sheet Amendment • November 4th, 2016 • CHC Group Ltd. • Air transportation, nonscheduled
This Amendment No.1 to Term Sheet (the “Amendment”) is entered into as of November 3, 2016, between CHC Group Ltd., as debtor and debtor in possession (“CHC”) and The Milestone Aviation Group Limited (“Milestone”) and amends the Term Sheet dated October 11, 2016 between CHC and Milestone (the “Term Sheet”).
AMENDMENT NO. 2 TO TERM SHEETTerm Sheet Amendment • April 14th, 2015 • Grilled Cheese Truck, Inc. • Retail-eating places • New York
This Amendment No. 2 (the "Amendment") dated November 17, 2014, to that certain term sheet (the "Term Sheet"), dated August 15, 2012, between TRIG Acquisition 1, Inc. (“Trig”) and Grilled Cheese Inc. (“GCT”, together with Trig, the “Company”) and Wesley K. Clark & Associates, LLC (the "Clark Group"), as amended by Amendment No. 2 to the Agreement, dated September 6, 2013 (“Amendment No. 1, together with the Term Sheet, collectively, the “Agreement”).
AMENDMENT NO. 1 TO TERM SHEETTerm Sheet Amendment • October 31st, 2013 • Consorteum Holdings, Inc. • Communications equipment, nec
THIS AMENDMENT NO. 1 TO TERM SHEET (this “Amendment”) is made and entered into as of May 22, 2013 by and among AIC, LLC (the “Lender” or “AIC”) and CONSORTEUM HOLDINGS, INC., a Nevada corporation (the “Borrower” or “CHI”).
AMENDMENT NO. 1 TO TERM SHEET, DATED AS OF NOVEMBER 11, 2022, BY AND AMONG MEDTECH ACQUISITION CORPORATION, TRISALUS LIFE SCIENCES, INC. AND MAGNETAR CAPITAL LLCTerm Sheet Amendment • March 8th, 2023 • MedTech Acquisition Corp • Services-medical laboratories • New York
This AMENDMENT NO. 1 TO TERM SHEET, dated as of March 4, 2023 (this “Amendment”), is hereby adopted, executed and agreed to by MedTech Acquisition Corporation (the “Issuer”), TriSalus Life Sciences, Inc. (the “Target”) and Magnetar Capital LLC, on behalf of one or more affiliates (the “Purchaser”, and together with the Issuer and the Target, the “Parties”).
